New heart failure drug shows early promise in small safety trial
Disease control
Completed
This early-stage study tested a new medicine called CDR132L in 28 people with stable heart failure caused by blocked arteries. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitor…
Phase: PHASE1 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated May 15, 2026 11:54 UTC